Table 1.
Grouping of the 47 EOC Study Cases Based on NKG2D Positivity, and Summary of Clinical Parameters
| Parameter | Total (N = 47) |
NKG2D Low (n = 24) |
NKG2D High (n = 23) |
|---|---|---|---|
| % NKG2D+ cells (median, min-max) | 1.79 (0.00-66.90) | 0.93 (0.00-1.79) | 12.87 (2.18-66.90) |
| Age (median, lowest-highest) | 61 (38-82) | 62 (38-82) | 59 (44-77) |
| FIGO stage (n, %) | |||
| I/II | 9 (19) | 6 (25) | 3 (13) |
| III/IV | 38 (81) | 18 (75) | 20 (87) |
| Outcome (n, %) | |||
| ANED | 27 (57) | 19 (79) | 8 (35) |
| Recurrence | 14 (30) | 3 (13) | 11 (48) |
| DOD | 6 (13) | 2 (8) | 4 (17) |
ANED, alive, no evidence of disease; DOD, died of disease.